Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 27 | 4 | OPHTHALMOLOGY//OPHTHALMOL//JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 152618 |
| 8 | 3 | OPHTHALMOLOGY//OPHTHALMOL//JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 152618 |
| 1964 | 2 | ADENO ASSOCIATED VIRUS//PEDF//PIGMENT EPITHELIUM DERIVED FACTOR | 6062 |
| 26837 | 1 | THERAPEUTIC TRANSGENES//ABT MED MOLEKULARGENET GENDIAGNOST//ANTERIOR SEGMENT CELLS | 264 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | THERAPEUTIC TRANSGENES | authKW | 159174 | 1% | 67% | 2 |
| 2 | ABT MED MOLEKULARGENET GENDIAGNOST | address | 119382 | 0% | 100% | 1 |
| 3 | ANTERIOR SEGMENT CELLS | authKW | 119382 | 0% | 100% | 1 |
| 4 | AUGENKLIN SMZ OST | address | 119382 | 0% | 100% | 1 |
| 5 | BARTS LONDON NHS TRUST QUEEN MARY | address | 119382 | 0% | 100% | 1 |
| 6 | BIOVECTYS | address | 119382 | 0% | 100% | 1 |
| 7 | CENTRO INVEST LASCARAY IKERGUNEA | address | 119382 | 0% | 100% | 1 |
| 8 | CLAYTON GENE THER Y | address | 119382 | 0% | 100% | 1 |
| 9 | CORNEA GENE THERAPY | authKW | 119382 | 0% | 100% | 1 |
| 10 | CORNEAL DISEASES AND DYSTROPHIES | authKW | 119382 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Ophthalmology | 10414 | 53% | 0% | 140 |
| 2 | Medicine, Research & Experimental | 1633 | 30% | 0% | 79 |
| 3 | Genetics & Heredity | 820 | 24% | 0% | 63 |
| 4 | Biotechnology & Applied Microbiology | 784 | 24% | 0% | 63 |
| 5 | Biochemistry & Molecular Biology | 120 | 21% | 0% | 56 |
| 6 | Transplantation | 43 | 3% | 0% | 8 |
| 7 | Immunology | 4 | 4% | 0% | 10 |
| 8 | Biochemical Research Methods | 2 | 2% | 0% | 5 |
| 9 | Surgery | 0 | 3% | 0% | 8 |
| 10 | Virology | 0 | 1% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ABT MED MOLEKULARGENET GENDIAGNOST | 119382 | 0% | 100% | 1 |
| 2 | AUGENKLIN SMZ OST | 119382 | 0% | 100% | 1 |
| 3 | BARTS LONDON NHS TRUST QUEEN MARY | 119382 | 0% | 100% | 1 |
| 4 | BIOVECTYS | 119382 | 0% | 100% | 1 |
| 5 | CENTRO INVEST LASCARAY IKERGUNEA | 119382 | 0% | 100% | 1 |
| 6 | CLAYTON GENE THER Y | 119382 | 0% | 100% | 1 |
| 7 | DRUG PROHIBIT | 119382 | 0% | 100% | 1 |
| 8 | EIE EYE STELLAR CHANCE S 310 | 119382 | 0% | 100% | 1 |
| 9 | ENDOTHELIAL CELLS | 119382 | 0% | 100% | 1 |
| 10 | FM KIRBY MED | 119382 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GENE THERAPY | 21968 | 10% | 1% | 27 |
| 2 | JOURNAL OF GENE MEDICINE | 10037 | 4% | 1% | 11 |
| 3 | HUMAN GENE THERAPY | 7931 | 6% | 0% | 15 |
| 4 | MOLECULAR VISION | 5137 | 5% | 0% | 12 |
| 5 | INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 5109 | 11% | 0% | 29 |
| 6 | CURRENT EYE RESEARCH | 4535 | 5% | 0% | 14 |
| 7 | EXPERIMENTAL EYE RESEARCH | 3492 | 5% | 0% | 14 |
| 8 | AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY | 2064 | 2% | 0% | 4 |
| 9 | OPHTHALMIC RESEARCH | 1999 | 2% | 0% | 6 |
| 10 | PROGRESS IN RETINAL AND EYE RESEARCH | 1612 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |